Indication
Postmenopausal osteoporosis
Postmenopausal osteoporosis is a systemic skeletal disorder that affects females following the cessation of ovarian function. Read more about Postmenopausal osteoporosis
91 drugs 59 manufacturers
Drugs that treat it
Common Postmenopausal osteoporosis therapies.
ALENDRONATE SODIUM
ALENDRONATE SODIUM
ALENDRONATE SODIUM
ALENDRONATE SODIUM
ALENDRONATE SODIUM
IBANDRONATE SODIUM
BINOSTO (alendronate sodium)
IBANDRONATE (ibandronate sodium)
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonPostmenopausal osteoporosis is a systemic skeletal disorder that affects females following the cessation of ovarian function.
It is characterized by low bone mineral density and the microarchitectural deterioration of bone tissue, driven primarily by estrogen deficiency that accelerates osteoclast-mediated bone resorption beyond the compensatory capacity of osteoblastic bone formation.
This progressive uncoupling of bone remodeling leads to structural fragility and a substantially heightened susceptibility to low-trauma or fragility fractures, most commonly involving the vertebrae, hip, and distal radius.
- nih.gov
Postmenopausal osteoporosis is a systemic skeletal disorder that affects females following the cessation of ovarian function It is characterized by low bone mineral density and the microarchitectural deterioration of bone tissue, driven primarily by estrogen deficiency that accelerates osteoclast-mediated bone resorption beyond the compensatory capacity of osteoblastic bone formation This progressive uncoupling of bone remodeling leads to structural fragility and a substantially heightened susce...
- nih.gov
Postmenopausal osteoporosis is a systemic skeletal disorder that affects females following the cessation of ovarian function
- nih.gov
It is characterized by low bone mineral density and the microarchitectural deterioration of bone tissue, driven primarily by estrogen deficiency that accelerates osteoclast-mediated bone resorption beyond the compensatory capacity of osteoblastic bone formation This progressive uncoupling of bone remodeling leads to structural fragility and a substantially heightened susceptibility to low-trauma or fragility fractures, most commonly involving the vertebrae, hip, and distal radius
- nih.gov
This progressive uncoupling of bone remodeling leads to structural fragility and a substantially heightened susceptibility to low-trauma or fragility fractures, most commonly involving the vertebrae, hip, and distal radius
Personalize your experience
Follow Postmenopausal osteoporosis and get updates as they land.
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.